Susceptibility to fluoroquinolones among commonly isolated Gram-negative bacilli in 2000: TRUST and TSN data for the United States

International Journal of Antimicrobial Agents

Volumn 19, Issue 1, 2002, Pages 21-31

  Karlowsky, James A ^a   Kelly, Laurie J ^a   Thornsberry, Clyde ^a   Jones, Mark E ^b   Evangelista, Alan T ^c   Critchley, Ian A ^a   Sahm, Daniel F ^a  

^a Focus Technologies Incorporated   (United States)

^b Focus Technologies   (Netherlands)

^c Ortho McNeil Pharmaceutical Incorporated   (United States)

Author keywords

Ciprofloxacin; Enterobacteriaceae; Levofloxacin; Non fermentative; Surveillance; TRUST; TSN

Indexed keywords

AMPICILLIN; CEFTAZIDIME; CEFTRIAXONE; CIPROFLOXACIN; COTRIMOXAZOLE; GATIFLOXACIN; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ACINETOBACTER BAUMANNII; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIUM ISOLATION; CITROBACTER; CONCENTRATION RESPONSE; DRUG MONITORING; DRUG SURVEILLANCE PROGRAM; ENTEROBACTER CLOACAE; ENTEROBACTERIACEAE; GRAM NEGATIVE BACTERIUM; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; PROTEUS MIRABILIS; PSEUDOMONAS AERUGINOSA; SERRATIA MARCESCENS; STENOTROPHOMONAS MALTOPHILIA;

ANTI-INFECTIVE AGENTS; DRUG RESISTANCE, BACTERIAL; FLUOROQUINOLONES; GRAM-NEGATIVE BACTERIA; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; MICROBIAL SENSITIVITY TESTS; POPULATION SURVEILLANCE; UNITED STATES; URINARY TRACT INFECTIONS;

EID: 0036158815     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-8579(01)00466-6     Document Type: Article

References (31)

1. Incidence of multi-resistant gram-negative isolates in eight Dutch hospitals. The 1990 Dutch Surveillance Study
2. Susceptibility surveillance among gram-negative bacilli at a cancer center
3. Evidence of interhospital transmission of extended-spectrum (β-lactam-resistant Klebsiella pneumoniae in the United States, 1986-1993
4. Antibiotic resistance caused by gram-negative multidrug efflux pumps
5. Multiple antibiotic-resistant Klebsiella pneumoniae and Escherichia coli in nursing homes
6. The epidemiology of bacterial resistance to quinolones
7. Prevalence of important pathogens and antimicrobial activity of parenteral drugs at numerous medical centers in the United States, I. Study on the threat of emerging resistances: Real or perceived?
8. Multicenter in vitro comparative study of fluoroquinolones against 25 129 gram-positive and gram-negative clinical isolates
9. Evaluation of current activities of fluoroquinolones against gram-negative bacilli using centralized in vitro testing and electronic surveillance
10. Levofloxacin. A review of its antibacterial activity, phamacokinetics and therapeutic efficacy
11. In vitro and in vivo antibacterial activities of levofloxacin (L-ofloxacin), an optically active ofloxacin
12. Levofloxacin in vitro activity: Results from an international comparative study with ofloxacin and ciprofloxacin
13. Levofloxacin: A therapeutic review
14. In vitro antibacterial activity of levofloxacin against hospital isolates: A multicentre study
15. Surveillance of antimicrobial resistance among gram-negative isolates from intensive care units in eight hospitals in Turkey
16. Bacterial resistance to ciprofloxacin in Greece: Results from the national electronic surveillance system
17. Comparative activities of six different fluoroquinolones against 9682 clinical bacterial isolates from 20 European university hospitals participating in the European SENTRY surveillance programme
18. Antimicrobial susceptibility and frequency of clinical blood isolates in Europe from the SENTRY antimicrobial surveillance program, 1997 and 1998
19. Survey of bloodstream infections due to gram-negative bacilli: Frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, and Latin America for the SENTRY antimicrobial surveillance program, 1997
20. Bacterial pathogens isolated from patients with bloodstream infection: Frequencies of occurrence and antimicrobial susceptibility patterns from the SENTRY antimicrobial surveillance program (United States and Canada, 1997)
21. Increasing resistance to fluoroquinolones in Escherichia coli from urinary tract infections in the Netherlands
22. The Surveillance Network™ (TSN™) - A powerful weapon in the fight against antibiotic resistance
23. Information technology: A means for enhancing surveillance of antimicrobial resistance
24. Antimicrobial resistance in key bloodstream isolates: Electronic surveillance with The Surveillance Network™ Database-USA
25. Multicenter in vitro comparative study of fluoroquinolones after 4 years of widespread clinical use
26. Prevalence of Acinetobacter spp. isolates with reduced susceptibility to imipenem, as determined by a USA-wide electronic surveillance network
27. Endemic carbapenem-resistant Acinetobacter species in Brooklyn, NY: Citywide prevalence, interinstitutional spread, and relation to antibiotic usage
28. Stenotrophomonas (Xanthomonas) maltophilia: A multidrug-resistant nosocomial pathogen
29. Comparative activity of new quinolones against 326 clinical isolates of Stenotrophomonas maltophilia